Novel bronchodilators in asthma
Authors:
- Mario CazzolaMCMario Cazzola
- Andrea SegretiASAndrea Segreti
- Maria G MateraMMMaria G Matera
- 1 January 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 16 (1) , 6-12
Abstract
Because of the central role of bronchodilators in the treatment of asthma, in recent years there has been a renewed interest in the field and now once-daily bronchodilators are in development in an attempt to simplify their use. A variety of beta2-agonists with long half-lives, also called ultra long-acting beta2-agonists (ultra-LABAs; indacaterol, carmoterol, milveterol, GSK-642444, BI-1744-CL, LAS-100977, and PF-00610355) are currently under development with the hopes of achieving once-daily dosing. Between them, indacaterol, GSK-642444, and carmoterol are at a more advanced stage of development. Also several novel inhaled long-acting antimuscarinic agents are currently being developed, but their role in the treatment of asthma is limited. As combination therapy with an inhaled corticosteroid (ICS) and a LABA is considered the first-line approach for treating patients suffering from asthma, some novel once-daily combinations of LABAs and ICSs are under development. Bronchodilators are central in the symptomatic management of asthma. It is likely that the once-daily dosing of a bronchodilator would be a significant convenience and probably a compliance-enhancing advantage, leading to improved overall clinical outcomes in patients with asthma. In any case, as a LABA in combination with an ICS continues to be the most effective asthma treatment, once-daily combinations of ultra-LABAs and ICSs will be central in the treatment of asthmatic patients in the next years.Keywords
This publication has 33 references indexed in Scilit:
- Emerging inhaled bronchodilators: an updateEuropean Respiratory Journal, 2009
- Novel long‐acting bronchodilators for COPD and asthmaBritish Journal of Pharmacology, 2008
- Improvements with tiotropium in COPD patients with concomitant asthmaRespiratory Medicine, 2008
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2007
- Adherence to treatment by patients with asthma or COPD: Comparison between inhaled drugs and transdermal patchRespiratory Medicine, 2007
- Ultra-Long-Acting ??2-Adrenoceptor AgonistsDrugs, 2007
- Safety of Long-Acting Beta-Agonists — An Urgent Need to Clear the AirNew England Journal of Medicine, 2005
- Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary diseaseExpert Opinion on Investigational Drugs, 2005
- Past, present and future—-adrenoceptor agonists in asthma managementRespiratory Medicine, 2005
- Once-Daily Inhaled Corticosteroids in Mild to Moderate AsthmaDrugs, 1999